[1] Hsia C C W. Tissue perfusion and diffusion and cellular respiration: transport and utilization of oxygen[J]. Semin Respir Crit Care Med,2023,44(5):594-611. [2] 尹紫悦,李豆豆,郭茜文,等. Hb构象变化对氧转运生理功能的影响[J]. 中南大学学报(医学版),2024,49(3):467-475. [3] Scholkmann F,Wolf M,Wolf U.Erythrocytes as active regulators of blood flow: a brief overview[C]//Oxygen Transport to Tissue XLVI. Cham:Springer Nature Switzerland,2026:133-141. [4] 齐畅,孟祥红. 红细胞免疫相关表面抗原及其功能[J]. 临床输血与检验,2024,26(6):855-858. [5] Kumar S D,Ghosh J,Ghosh S,et al.Emerging concepts in the molecular cell biology and functions of mammalian erythrocytes[J]. J Biol Chem,2025,301(4):108331. [6] Giri A,Tamgadge S.Red blood cells in health and disease[J]. J Microsc Ultrastruct,2025,13(3):130-136. [7] Papadopoulos C.Molecular and immunometabolic landscape of erythrophagocytosis-induced ferroptosis[J]. CHDDT,2025,25(2):79-86. [8] Clementi A,Virzì G M,Milan Manani S,et al.Eryptosis in patients with chronic kidney disease: a possible relationship with oxidative stress and inflammatory markers[J]. J Clin Med,2022,11(23):7167. [9] Deng X,Gong X Y,Huang Y,et al.Eryptosis in renal anemia: mechanisms,clinical implications,and therapeutic targeting[J]. Front Pharmacol,2025,16:1718803. [10] Lang K,Lang P,Bauer C,et al.Mechanisms of suicidal erythrocyte death[J]. Cell Physiol Biochem,2005,15(5): 195-202. [11] Chen Y Z,Chen S W,Liu Z X,et al. Red blood cells undergo lytic programmed cell death involving NLRP3[J]. Cell,2025,188(11):3013-3029.e19. [12] Tweedell R E,Kanneganti T D.ExSPECKt the unexpected: NLRP3-caspase-8-dependent cell death in RBCs[J]. Cell,2025,188(11):2833-2835. [13] Derry P J,Vo A T T,Gnanansekaran A,et al. The chemical basis of intracerebral hemorrhage and cell toxicity with contributions from eryptosis and ferroptosis[J]. Front Cell Neurosci,2020,14:603043. [14] Tkachenko A,Quintanar-Escorza M A,Tryfonyuk L, et al. New insights into the multifaceted role of eryptosis in metabolic and cardiovascular diseases[J]. Biochim Biophys Acta BBA Mol Cell Res,2026,1873(5):120161. [15] Jemaà M,Mokdad Gargouri R,Lang F.Polo-like kinase inhibitor BI2536 induces eryptosis[J]. Wien Med Wochenschr,2023,173(5/6):152-157. [16] Virzì G M,Clementi A,Ronco C,et al.Red cell death in renal disease: the role of eryptosis in CKD and dialysis patients[J]. Cells,2025,14(13):967. [17] Coombs J R,Burgener S S,Schroder K.Spectosis: dying for a complement[J]. Immunity,2025,58(6):1372-1374. [18] Kobayashi N, Karisola P, Peña-Cruz V, et al.TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells[J]. Immunity,2007, 27(6):927-940. [19] Alfhili M A,Alsughayyir J.Bufalin reprograms erythrocyte lifespan through p38 MAPK and Rac1 GTPase[J]. Toxicon,2024,240:107636. [20] 王琨,韩强,彭书华,等. 溶血性贫血突变小鼠中锚蛋白外翻介导的红细胞吞噬作用[J]. 中国药业,2022,31(10): 45-50. [21] Restivo I,Giardina I C,Barone R,et al.Indicaxanthin prevents eryptosis induced by cigarette smoke extract by interfering with active Fas-mediated signaling[J]. BioFactors,2024,50(5):997-1008. [22] Brun J F,Varlet-Marie E,Myzia J,et al.Metabolic influences modulating erythrocyte deformability and eryptosis[J]. Metabolites,2021,12(1):4. [23] Jalink M,de Boer E C W,Evers D,et al. Halting targeted and collateral damage to red blood cells by the complement system[J]. Semin Immunopathol,2021, 43(6):799-816. [24] Evangelidis P,Evangelidis N,Vlachaki E,et al.What is the role of complement in bystander hemolysis? Old concept, new insights[J]. Expert Rev Hematol,2024,17(4/5):107-116. [25] Mukherjee D,Kaur P,Singh A,et al.Advancements in Autoimmune Hemolytic Anemia (AIHA) treatment: Exploring emerging therapies[J]. Leuk Res,2025,156: 107910. [26] Kamhieh-Milz J,Bartl B,Sterzer V,et al.Storage of RBCs results in an increased susceptibility for complement-mediated degradation[J]. Transfus Med,2014,24(6):392-399. [27] LaRocca T J,Stivison E A,Hod E A,et al. Human-specific bacterial pore-forming toxins induce programmed necrosis in erythrocytes[J]. mBio,2014,5(5):e01251-e01214. [28] 李晓英,芶大明. 红细胞衰亡与红细胞膜磷脂酰丝氨酸外翻机制研究进展[J]. 国际麻醉学与复苏杂志,2016, 37(5):464-467. [29] Gao M,Liu Y,Chen Y,et al.miR-214 protects erythroid cells against oxidative stress by targeting ATF4 and EZH2[J]. Free Radic Biol Med,2016,92:39-49. [30] Tkachenko A,Havranek O.Erythronecroptosis: an overview of necroptosis or programmed necrosis in red blood cells[J]. Mol Cell Biochem,2024,479(12):3273-3291. [31] Bissinger R,Nemkov T,D'Alessandro A,et al. Proteinuric chronic kidney disease is associated with altered red blood cell lifespan,deformability and metabolism[J]. Kidney Int,2021,100(6):1227-1239. [32] Bissinger R,Schaefer L,Bohnert B N,et al.GFR is a key determinant of red blood cell survival in anemia associated with progressive CKD[J]. Kidney Int Rep, 2025,10(3):730-742. [33] Tozoni S S,Dias G F,Bohnen G,et al.Uremia and hypoxia independently induce eryptosis and erythrocyte redox imbalance[J]. Cell Physiol Biochem,2019,53:794-804. [34] Van Spitzenbergen B A K,Andrade G B,Dias E S,et al. The uremic solute 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) may enhance eryptosis and increase erythrocyte osmotic fragility through potential activation of PIEZO1[J]. Nephrol Dial Transplant,2025, 40(7):1342-1349. [35] Kotanko P,Jörg D J,Grobe N,et al.The Piezo1 hypothesis of renal anemia[J]. FASEB BioAdvances, 2022,4(7):436-440. [36] Abed M,Artunc F,Alzoubi K,et al.Suicidal erythrocyte death in end-stage renal disease[J]. J Mol Med (Berl), 2014,92(8):871-879. [37] Dias G F,Tozoni S S,Bohnen G,et al.Effect of hypoxia and uremia on oxidative stress on erythrocytes from hemodialysis patients[J]. Cell Biochem Funct,2022, 40(8):856-864. [38] Dias G F,Tozoni S S,Bohnen G,et al.Uremia and inadequate oxygen supply induce eryptosis and intracellular hypoxia in red blood cells[J]. Cell Physiol Biochem,2021,55(4):449-459. [39] Ma J,Dou Y N,Zhang H J,et al.Correlation between inflammatory biomarkers and red blood cell life span in chronic hemodialysis patients[J]. Blood Purif,2017, 43(1/2/3):200-205. [40] Lang F,Jilani K,Lang E.Therapeutic potential of manipulating suicidal erythrocyte death[J]. Expert Opin Ther Targets,2015,19(9):1219-1227. [41] Fonseca L L,Alezi H S,Moreno A,et al.Quantifying the removal of red blood cells in Macaca mulatta during a Plasmodium coatneyi infection[J]. Malar J,2016,15(1):410. [42] Ramírez-Guerrero G,De Cal M,Perin N,et al.Evaluation of eryptosis induced by bacterial concentrations in sepsis: a translational approach[J]. Blood Purif,2026:1. [43] Virzì G M,Clementi A,Zanella M,et al.Eryptosis in acute patients: a hypothesis on its potential clinical impact and current gaps in evidence[J]. Curr Issues Mol Biol,2026,48(1):65. [44] Soma P, Bester J.Pathophysiological Changes in Erythrocytes Contributing to Complications of Inflammation and Coagulation in COVID-19[J]. Front Physiol. 2022,13: 899629. [45] Tkachenko A,Havránek O.Redox status of erythrocytes as an important factor in eryptosis and erythronecroptosis[J]. Folia Biol,2023,69(4):116-126. [46] LaRocca T J,Stivison E A,Mal-Sarkar T,et al. CD59 signaling and membrane pores drive Syk-dependent erythrocyte necroptosis[J]. Cell Death Dis,2015,6(5): e1773. [47] Navaneethabalakrishnan S,An X L,Vinchi F.Heme- and iron-activated macrophages in sickle cell disease: an updated perspective[J]. Curr Opin Hematol,2024, 31(6):275-284. [48] Ramires M L V,Leite M F B,Lo D Z Y,et al. Relation between red blood cell distribution width and acute kidney injury in patients with sepsis[J]. Einstein (Sao Paulo),2022,20:eAO6828. [49] Zhang M, Liu M, Yang L, et al.Increased ferroptosis of erythrocytes is associated with myelodysplastic syndromes[J]. Ann Hematol,2024,103(10):4009-4020. [50] Lang E,Lang F.Mechanisms and pathophysiological significance of eryptosis,the suicidal erythrocyte death[J]. Semin Cell Dev Biol,2015,39:35-42. [51] Lang F,Lang E,Föller M.Physiology and pathophysiology of eryptosis[J]. Transfus Med Hemother,2012,39(5):308-314. [52] Lang E,Qadri S M,Lang F.Killing me softly-Suicidal erythrocyte death[J]. Int J Biochem Cell Biol,2012, 44(8):1236-1243. [53] Lin S Y,Zheng Y P,Chen M H,et al.The interactions between ineffective erythropoiesis and ferroptosis in β-thalassemia[J]. Front Physiol,2024,15:1346173. [54] Restivo I,Attanzio A,Tesoriere L,et al.Suicidal erythrocyte death in metabolic syndrome[J]. Antioxidants (Basel),2021,10(2):154. [55] Lang F,Abed M,Lang E,et al.Oxidative stress and suicidal erythrocyte death[J]. Antioxid Redox Signal, 2014,21(1):138-153. [56] Lang E,Bissinger R,Gulbins E,et al.Ceramide in the regulation of eryptosis,the suicidal erythrocyte death[J]. Apoptosis,2015,20(5):758-767. [57] Sommer M.Anemia: normocytic anemia[J]. FP Essent, 2023,530:22-33. [58] Zaitsev S, Kowalska M A, Neyman M, et al.Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis[J]. Blood,2012,119(21):4779-4785. [59] Villa C H, Anselmo A C, Mitragotri S, et al.Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems[J]. Adv Drug Deliv Rev,2016,106(Pt A):88-103. [60] Li Z L,Shen L,Tu Y,et al.Hypoxia-inducible factor-prolyl hydroxylase inhibitors in treatment of anemia with chronic disease[J]. Chin Med J,2025,138(12):1424-1432. [61] 高瞻,肖军,李小薇,等. 低氧诱导因子HIF-2α调控红细胞生成的研究进展[J]. 临床输血与检验,2021,23(5):561-564. |